Search Results 1-10 of 15939 for GLP-1 agonist

  1. Diabetes drugs and weight loss - Mayo Clinic

    GLP-1 agonists mimic the way a hormone called glucagon-like peptide 1 works in the body. When blood sugar starts to rise after a person eats, these medicines ...

  2. A Study Of GLP-1 Receptor Agonists On Reproductive Health In Women - Mayo Clinic

    ... GLP-1 agonists during their reproductive years. To understand the efficacy each available GLP-1 agonist or dual agonist may have on reproductive health.

  3. Examining the impact of GLP-1 receptor agonist use on quality of bowel preparation for colonoscopy - Mayo Clinic

    The rapidly rising use of glucagon-like peptide-1 (GLP-1) receptor agonists has caused gastroenterologists to question whether these medications can affect ...

  4. Preoperative Gastric Content With Ultrasound Assessment in Patients Taking GLP1 Agonists - Mayo Clinic

    ... glucagon-like peptide 1 (GLP-1) agonist medications compared to patients who do not take GLP-1 agonists. Participation eligibility. Participant eligibility ...

  5. Semaglutide (subcutaneous route) - Side effects & dosage - Mayo Clinic

    Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist. Semaglutide injection is also used together with diet and exercise to help lose weight ...

  6. Evaluation of the changes in glycemic and physiologic parameters (sleep, cardioadapatbility parameters) in non-diabetic patients being treated for obesity with GLP1 Agonist and GLP-1/ GIP agonist medications. - Mayo Clinic

    ... GLP1 Agonist and GLP-1/ GIP agonist medications. Print details. Share ... It is proposed that participants will wear the devices for a period of 28 days before ...

  7. GLP-1RA and thyroid cancer: New study suggests detection bias, not causation - Mayo Clinic

    Glucagon-like peptide 1 receptor agonists (GLP-1RAs) are cornerstone therapies for type 2 diabetes, obesity and cardiovascular health.

  8. Effects Of Long-Acting GLP-1 (Glucagon-like Peptide-1) Or Dual Incretin (GLP-1 And GIP [Glucose-dependent Insulinotropic Peptide]) Modulation On Gastric Motor Functions - Mayo Clinic

    * Patients with T2DM on GLP-1RAs, amylin agonists/analogs (e.g. pramlintide), insulin, sulfonylureas (all due to risk of hypoglycemia with semaglutide or ...

  9. Effect of GLP-1 Receptor Agonism After Sleeve Gastrectomy - Mayo Clinic

    In this study the investigators propose to randomize subjects undergoing SG to receive either placebo or Liraglutide, a GLP-1 receptor agonist, to compare ...

  10. Contribution of GLP-1 Receptor - Mayo Clinic

    The GLP-1 receptor gene is found on the beta cells of the pancreas. Its role is in the control of blood sugar level by enhancing insulin secretion from the ...